Corsello Antonio, Milani Gregorio Paolo, Giannì Maria Lorella, Dipasquale Valeria, Romano Claudio, Agostoni Carlo
Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.
Pediatric Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Healthcare (Basel). 2022 Jun 1;10(6):1023. doi: 10.3390/healthcare10061023.
Vitamin D (VD) is an essential micronutrient with multiple functions for human growth, and adequate intake should be guaranteed throughout life. However, VD insufficiency is observed in infants all over the world. Low VD concentration in the breast milk of non-supplemented mothers and low compliance to VD daily supplementation are the main causes of VD insufficiency, especially in the long term. Furthermore, VD supplementation dosages are still debated and differ by country. We conducted a systematic review to compare the most recent evidence on different postnatal VD supplementation strategies, determining whether supplementation given to the mother is as effective as that administered directly to the child, and whether different dosages and administration schedules differ significantly in terms of efficacy and safety. We identified 18 randomized controlled trials (RCTs) addressing the role of infant (n = 961), maternal (n = 652) or combined infant and maternal VD supplementation (n = 260 pairs). In all studies, similar outcomes emerged in terms of efficacy and safety. According to our findings, alternative approaches of VD supplementation may be adopted, especially in cases where the adherence to daily supplementation strategies is poor. This review shows that different dosages and supplementation strategies result in similar VD sufficiency rates. Therefore, international guidelines may be revised in the future to offer multiple and different options of supplementation for specific settings and ages.
维生素D(VD)是一种对人类生长具有多种功能的必需微量营养素,一生中都应保证充足摄入。然而,世界各地的婴儿都存在VD不足的情况。未补充VD的母亲母乳中VD浓度低以及VD每日补充的依从性差是VD不足的主要原因,尤其是从长期来看。此外,VD补充剂量仍存在争议,且因国家而异。我们进行了一项系统综述,以比较不同产后VD补充策略的最新证据,确定给母亲补充是否与直接给孩子补充一样有效,以及不同剂量和给药方案在疗效和安全性方面是否存在显著差异。我们确定了18项随机对照试验(RCT),涉及婴儿(n = 961)、母亲(n = 652)或婴儿与母亲联合VD补充(n = 260对)的作用。在所有研究中,在疗效和安全性方面都出现了类似的结果。根据我们的研究结果,可以采用替代的VD补充方法,特别是在每日补充策略依从性差的情况下。本综述表明,不同剂量和补充策略导致的VD充足率相似。因此,未来可能会修订国际指南,为特定情况和年龄提供多种不同的补充选择。